Organic Letters
Letter
Claisen Rearrangement: Methods and Applications; Hiersemann, M.,
Nubbemeyer, U., Eds.; Wiley-VCH: Weinheim, 2007; pp 117−210.
(c) Ilardi, E. A.; Stivala, C. E.; Zakarian, A. Chem. Soc. Rev. 2009, 38,
3133−3148.
(13) For a precedent for simultaneous construction of contiguous
tetrasubstituted stereocenters by an Ireland−Claisen rearrangement of
cyclohex-2-enyl esters, see: Gu, Z.; Herrmann, A. T.; Stivala, C. E.;
Zakarian, A. Synlett 2010, 1717−1722.
(14) (a) Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155−
4156. (b) Dess, D. B.; Martin, J. C. J. Am. Chem. Soc. 1991, 113, 7277−
7287.
(15) For a review on Henry reaction, see: Luzzio, F. A. Tetrahedron
2001, 57, 915−945.
(16) For recent reviews on 1,3-dipolar cycloadditions, see: (a) Nair,
V.; Suja, T. D. Tetrahedron 2007, 63, 12247−12275. (b) Rane, D.; Sibi,
M. Curr. Org. Synth. 2011, 8, 616−627. (c) Browder, C. C. Curr. Org.
Synth. 2011, 8, 628−644.
In summary, we have achieved a stereoselective synthesis of
the [6,5,5]-tricyclic ring portion of scillascilloside E-1. This
synthesis features simultaneous and stereoselective construction
of the contiguous tetrasubstituted stereocenters (C13 and C17)
by an Ireland−Claisen rearrangement and D ring formation by
an intramolecular nitrile oxide cycloaddition. Further efforts
toward a total synthesis of scillascilloside E-1 are currently
underway in our laboratory and will be reported in due course.
ASSOCIATED CONTENT
* Supporting Information
■
S
Experimental procedures and full characterization data for all
new compounds. This material is available free of charge via the
(17) For combinational use of Ireland−Claisen rearrangement and
intramolecular nitrile oxide cycloaddition for the synthesis of bicyclic
compounds, see: (a) Mulzer, J.; Castagnolo, D.; Felzmann, W.;
Marchart, S.; Pilger, C.; Enev, V. S. Chem.Eur. J. 2006, 12, 5992−
6001. (b) Enev, V. S.; Drescher, M.; Mulzer, J. Tetrahedron 2007, 63,
AUTHOR INFORMATION
Corresponding Author
■
Notes
5930−5939. (c) Parthasarathy, G.; Besnard, C.; Kundig, E. P. Chem.
̈
The authors declare no competing financial interest.
Commun. 2012, 48, 11241−11243.
(18) Mukaiyama, T.; Hoshino, T. J. Am. Chem. Soc. 1960, 82, 5339−
ACKNOWLEDGMENTS
5342.
■
(19) For a review on cleavage of isoxazolines, see: Nagireddy, J. R.;
Raheem, M.-A.; Haner, J.; Tam, W. Curr. Org. Synth. 2011, 8, 659−
700.
(20) The stereochemistry at C20 of major isomer 29 was confirmed
by a crosspeak between C20-CH3 and C23-H in the NOESY spectrum
of enone 4.
(21) A similar observation was made by Kobayashi and co-workers
during their synthesis of fomitellic acid B. See ref 4.
(22) For a review on heteroatom-directed organic reactions, see:
Hoveyda, A. H.; Evans, D. A.; Fu, G. C. Chem. Rev. 1993, 93, 1307−
1370.
This research was supported in part by the Japan Society for the
Promotion of Science (Grant-in-Aid for Scientific Research),
the Ministry of Education, Culture, Sports, Science and
Technology, Japan (Platform for Drug Discovery, Informatics,
and Structural Life Science), the Uehara Memorial Foundation,
and the Naito Foundation. We are grateful to the Fukuyama
group of Nagoya University for the use of their mass
spectrometer.
REFERENCES
■
(23) Gemal, A. L.; Luche, J.-L. J. Am. Chem. Soc. 1981, 103, 5454−
5459.
(1) Sholichin, M.; Miyahara, K.; Kawasaki, T. Chem. Pharm. Bull.
1985, 33, 1756−1759.
(24) (a) Furukawa, J.; Kawabata, N.; Nishimura, J. Tetrahedron Lett.
1966, 3353−3354. (b) Furukawa, J.; Kawabata, N.; Nishimura, J.
Tetrahedron 1968, 24, 53−58.
(25) The stereochemistry at C14 was unambiguously confirmed by a
crosspeak between C14-CH3 and C9-Hax in the NOESY spectrum of
ketone 3.
(2) Lee, S.-M.; Chun, H.-K.; Lee, C.-H.; Min, B.-S.; Lee, E.-S.; Kho,
Y.-H. Chem. Pharm. Bull. 2002, 50, 1245−1249.
(3) Corey, E. J.; Lee, J.; Liu, D. R. Tetrahedron Lett. 1994, 35, 9149−
9152.
(4) Yamaoka, M.; Nakazaki, A.; Kobayashi, S. Tetrahedron Lett. 2009,
50, 6764−6768.
(5) Akahori, Y.; Yamakoshi, H.; Sawayama, Y.; Hashimoto, S.;
Nakamura, S. J. Org. Chem. 2014, 79, 720−735.
(6) ter Halle, R.; Bernet, Y.; Billard, S.; Bufferne, C.; Carlier, P.;
Delaitre, C.; Flouzat, C.; Humblot, G.; Laigle, J. C.; Lombard, F.;
Wilmouth, S. Org. Process Res. Dev. 2004, 8, 283−286.
(7) Wang, C.; Forsyth, C. J. Org. Lett. 2006, 8, 2997−3000.
(8) (a) Wenkert, E.; McPherson, C. A. J. Am. Chem. Soc. 1972, 94,
́
8084−8090. (b) Schollkopf, U.; Banhidai, B.; Frasnelli, H.; Meyer, R.;
̈
Beckhaus, H. Liebigs Ann. Chem. 1974, 1767−1783.
(9) Frigerio, M.; Santagostino, M. Tetrahedron Lett. 1994, 35, 8019−
8022.
(10) (a) Moyer, M. P.; Feldman, P. L.; Rapoport, H. J. Org. Chem.
1985, 50, 5223−5230. (b) Heslin, J. C.; Moody, C. J. J. Chem. Soc.,
Perkin Trans. 1 1988, 1417−1423. (c) Moody, C. J.; Taylor, R. J. J.
Chem. Soc., Perkin Trans. 1 1989, 721−731. (d) Cox, G. G.; Moody, C.
J.; Austin, D. J.; Padwa, A. Tetrahedron 1993, 49, 5109−5126.
(11) (a) Lebel, H.; Paquet, V.; Proulx, C. Angew. Chem., Int. Ed. 2001,
40, 2887−2890. (b) Lebel, H.; Paquet, V. J. Am. Chem. Soc. 2004, 126,
320−328. (c) Lebel, H.; Guay, D.; Paquet, V.; Huard, K. Org. Lett.
2004, 6, 3047−3050.
(12) For reviews on Ireland−Claisen rearrangements, see: (a) Chai,
Y.; Hong, S.-P.; Lindsay, H. A.; McFarland, C.; McIntosh, M. C.
Tetrahedron 2002, 58, 2905−2928. (b) McFarland, C. M.; McIntosh,
M. C. The Ireland−Claisen Rearrangement (1972−2004). In The
2057
dx.doi.org/10.1021/ol500657f | Org. Lett. 2014, 16, 2054−2057